Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31/12/2025 | 31/12/2024 |
|---|---|---|
| Revenue | 166M | 191M |
| Cost of revenue | 95M | 122M |
| Gross profit | 71M | 69M |
| Research and development | 20M | 21M |
| Selling, general and administrative | 21M | 17M |
| Operating expenses | 67M | 67M |
| Operating income | 4M | 2M |
| Pre-tax income | 1M | −14M |
| Income tax | 44,000 | 689,000 |
| Net income | 838,000 | 5M |
| Earnings per share | −0.18 | 0.10 |
| Earnings per share, diluted | −0.18 | 0.10 |
| Weighted average shares | 15M | 13M |
| Weighted average shares, diluted | 15M | 13M |
| Metric | 31/03/2026 | 31/12/2025 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 31/12/2024 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 19M | 25M | 15M | 13M | 35M | 40M | 12M | 43M |
| Receivables | 16M | 25M | 28M |
| Metric | 31/12/2025 | 31/12/2024 |
|---|---|---|
| Operating cash flow | 7M | 34M |
| Depreciation and amortisation | 8M | 13M |
| Share-based compensation | 7M | 4M |
| Capital expenditure | 661,000 | 100,000 |
| Investing cash flow | −9M | 43M |
| Financing cash flow | −13M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 24M |
| 12M |
| 14M |
| 16M |
| 21M |
| Inventory | 13M | 8M | 9M | 15M | 15M | 14M | 18M | 18M |
| Current assets | 53M | 64M | 57M | 56M | 66M | 73M | 85M | 93M |
| Goodwill | 4M | 4M | 4M | 4M | 4M | 4M | 4M | 22M |
| Total assets | 84M | 94M | 86M | 83M | 93M | 100M | 113M | 150M |
| Current liabilities | 52M | 48M | 44M | 46M | 59M | 63M | 189M | 239M |
| Short-term debt | — | — | — | — | — | — | 6M | 14M |
| Total liabilities | 110M | 98M | 94M | 94M | 106M | 113M | 198M | 251M |
| Equity | −25M | −4M | −8M | −10M | −13M | −13M | −85M | −102M |
| Shares outstanding | 16M | 15M | 15M | 15M | 15M | 15M | 13M | 12M |
| Shares issued | 16M | 15M | 15M | 15M | 15M | 15M | 13M | 12M |
| −39M |